Drugs / S-pantoprazole
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT01821521 | Jun → Aug 2013 | — | Ahn-Gook Pharmaceuticals Co.,Ltd | Unknown | No outcome recorded |
| Phase 1 | NCT01882296 | ? → Sep 2013 | — | Ahn-Gook Pharmaceuticals Co.,Ltd | Unknown | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT02274961 | Oct 2014 → Jul 2015 | gastroesophageal reflux disease | Ahn-Gook Pharmaceuticals Co.,Ltd | Unknown | No outcome recorded |
| Phase 3 | NCT01400945 | Dec 2009 → Aug 2011 | gastroesophageal reflux disease | Ahn-Gook Pharmaceuticals Co.,Ltd | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | S-pantoprazole | “Investigate a Pharmacodynamics Between S-pantoprazole 10, 20, 40mg and Pantoprazole 20, 40mg in Healthy Male Subjects” NCT01882296 ↗3“Investigate a Pharmacokinetics Between S-pantoprazole 20mg and Pantoprazole 40mg in Healthy Male Subjects” NCT01821521 ↗ |
| Route | Oral | “Multiple Oral Dosing” NCT01882296 ↗ |